A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer.
Panagiotis A KonstantinopoulosElizabeth K LeeNiya XiongCarolyn KrasnerSusana CamposDavid L KolinJoyce F LiuNeil HorowitzAlexi A WrightSara BouberhanRichard T PensonOladapo O YekuBrittany BowesHope NeedhamMartin HayesHannah SawyerMadeline PolakMeghan SheaSu-Chun ChengCesar M CastroUrsula A MatulonisPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Letrozole/abemaciclib demonstrated encouraging and durable evidence of activity in recurrent ER positive endometrioid EC.